The 12th meeting of the Diabetes in Pregnancy Study Group of North America (DPSG-NA): introduction and overview.
Citation: Journal of Maternal-Fetal & Neonatal Medicine. 25(1):3-4, 2012 Jan.PMID: 21954980Institution: MedStar Washington Hospital CenterDepartment: Obstetrics and Gynecology/Maternal-Fetal MedicineForm of publication: Journal ArticleMedline article type(s): Comment | Journal ArticleSubject headings: *Diabetes, Gestational/pp [Physiopathology] | *Fetal Diseases/et [Etiology] | *Maternal-Fetal Ex130912/ph [Physiology] | *Metabolic Syndrome X/pp [Physiopathology] | *Mothers | *Obesity/et [Etiology] | Female | Humans | PregnancyLocal holdings: Available online through MWHC library: 2013 to the presentISSN:- 1476-4954
Item type | Current library | Collection | Call number | Status | Date due | Barcode |
---|---|---|---|---|---|---|
Journal Article | MedStar Authors Catalog | Article | Available | 21954980 |
Available online through MWHC library: 2013 to the present
The Diabetes in Pregnancy Study Group of North America (DPSG-NA) held its 12th meeting April 1-2, 2011 in Washington DC. The meeting, which was co-hosted by the Washington Hospital Center and the University of Maryland School of Medicine focused on five broad themes: (i) the prevention of diabetes and its risk factors, such as obesity, in pregnancy; (ii) the appropriate use of pharmacotherapies for managing diabetes in pregnancy; (iii) optimal glycemic control; (iv) the value of nutrition, exercise and limiting weight gain during pregnancy and (v) the diagnosis and consequences of diabetic fetopathy. These proceedings reflect peer-reviewed papers of data presented at the meeting. Time also was allocated to discuss the perceived barriers to using the one-step, 75 g oral glucose tolerance test as the first-line approach to diagnosing gestational diabetes mellitus. Responses from a survey of participants on perceived barriers to adopting this method into widespread clinical practice are discussed.
English